Boosteroid was established in 2016 in Ukraine and launched commercially in 2019. Currently, the company is headquartered in Austin, Texas with its main R&D office based in Kyiv, Ukraine, and several local entities operating in the EU. As of early 2025, Boosteroid has a team of 120+ people.
They once were an Ukrainian company, but currently they're American with some satellite offices in the EU, it seems.